An Anthropic AI model that can find zero-days in every major operating system has become a geopolitical and prudential question. The Eurogroup met in Brussels on Monday with no answer in hand. Brussels on a Monday morning in early May is not, by tradition, the place where the world’s most powerful AI model gets discussed. […]
A new Bloomberg-Feroot investigation finds that nine of the 10 largest US health companies are still loading advertising trackers on the very pages where patients log in and register. The story keeps repeating because nothing has stopped it. There is, by now, a familiar shape to investigations of online tracking. A reporter or researcher loads […]
OpenAI has finalised the most structurally novel enterprise AI deal of 2026: a $10bn vehicle anchored by TPG, with 19 investors and a 17.5% guaranteed annual return over five years. The strategy is to make PE portfolios a captive distribution channel. We wrote about the venture’s outline last month; Monday’s confirmation closes the funding question. […]
Blackstone Digital Infrastructure Trust will list on the NYSE under BXDC, targeting newly built data centres leased to hyperscalers. It is the most direct way Wall Street has yet packaged the AI build-out for public investors. For most of the past 18 months, the financial story behind the AI build-out has been a story about […]
After a 30% year-to-date drawdown, Monday’s Q1 results are Palantir’s first chance to argue, not assume, that it does not belong in the broader AI software multiple compression. Until two weeks ago, Palantir was, by some measures, the best-performing large-cap software stock of the AI cycle. It had outpaced Salesforce, Microsoft, Oracle, and Adobe by […]
Three days after suggesting it might target up to $4bn at $40bn, the AI chipmaker has marketed 28 million shares at $115-$125 each, lining the deal up with its February private valuation rather than above it. Cerebras Systems was preparing to seek up to $4bn at a roughly $40bn valuation in its long-awaited initial public […]
The Belgian pharma is buying a two-year-old San Diego biotech for $2bn upfront, the second TCE bet it has placed in months. The thesis: B-cell killers built for cancer can rewire how autoimmune diseases are treated. Candid Therapeutics is two years old. It does not have an approved drug. Its lead programme has been tested […]
A joint venture with Blackstone, Hellman & Friedman, Goldman Sachs, and General Atlantic will sell Claude into the buyout firms’ portfolio companies. OpenAI’s DeployCo arrived first; this one is bigger. There is a kind of business school question that has been quietly answered over the past month, without anyone formally asking it. The question is: […]
Update, 4 May, 12:30 Phase two of New Mexico v. Meta Platforms opened on Monday in Santa Fe with three meaningful additions to what was previously known. According to Reuters, state Attorney General Raúl Torrez’s office is now expected to call roughly 15 witnesses, including expert testimony on the technical feasibility of the proposed remedies, […]
Won-Jin Lee, a marketing veteran, takes over the Visual Display business after a quarter of declining TV profits. His predecessor moves to AI and robotics. Samsung Electronics has changed the head of its television business for the first time in more than two years, an unusually direct admission that something is not quite right at […]
